A Rapid, Cost-Effective Pre-Clinical Method to Screen for Pro- or Antiarrhythmic Effects of Substances in an Isolated Heart Preparation

por Borg, John Joseph
Publicado 2015

Alzheimer’s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?

por Melchiorri, Daniela, Merlo, Sara, Micallef, Benjamin, Borg, John-Joseph, Dráfi, František
Publicado 2023

Reflections on Decisions Made on the Well-Established Use of Medicinal Products by EU Regulators and the ECJ

por Borg, John Joseph, Laslop, Andrea, Pani, Luca, Maciulaitis, Romaldas, Melchiorri, Daniela
Publicado 2014

Changing paradigms in bioequivalence trials submitted to the EMA for evaluation – A clinical and regulatory perspective

por Refalo, Nathaniel, Chetcuti, Daniel, Tanti, Amy, Serracino-Inglott, Anthony, Borg, John Joseph
Publicado 2017

Editorial: Pharmacology of autoimmune and neuroinflammatory disease from a preclinical and clinical perspective

por Šíma, Martin, Laslop, Andrea, Borg, John Joseph, Poništ, Silvester, Melchiorri, Daniela, Dráfi, František
Publicado 2023

Licensing of Generic Medicines: Are There Any Challenges Left? A Pharmaceutical Regulatory Perspective

por Borg, John Joseph, Tomasi, Paolo, Pani, Luca, Aislaitner, George, Pirozynski, Michal, Leufkens, Hubert, Melchiorri, Daniela
Publicado 2014

A Healthy Gut for a Healthy Brain: Preclinical, Clinical and Regulatory Aspects

por Petrella, Carla, Farioli-Vecchioli, Stefano, Cisale, Giusy Ylenia, Strimpakos, Georgios, Borg, John Joseph, Ceccanti, Mauro, Fiore, Marco, Monteleone, Giovanni, Nisticò, Robert
Publicado 2021